OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Duloxetine plasma level and antidepressant response
Domenico De Donatis, Vincenzo De Florio, Stefano Porcelli, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 92, pp. 127-132
Closed Access | Times Cited: 28
Domenico De Donatis, Vincenzo De Florio, Stefano Porcelli, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 92, pp. 127-132
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Antidepressant drugs as emerging contaminants: Occurrence in urban and non-urban waters and analytical methods for their detection
Carlos Castillo-Zacarías, Mario E. Barocio, Enrique Hidalgo-Vázquez, et al.
The Science of The Total Environment (2020) Vol. 757, pp. 143722-143722
Closed Access | Times Cited: 146
Carlos Castillo-Zacarías, Mario E. Barocio, Enrique Hidalgo-Vázquez, et al.
The Science of The Total Environment (2020) Vol. 757, pp. 143722-143722
Closed Access | Times Cited: 146
Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019)
Pablo de María, Gonzalo de Gonzalo, Andrés R. Alcántara
Catalysts (2019) Vol. 9, Iss. 10, pp. 802-802
Open Access | Times Cited: 83
Pablo de María, Gonzalo de Gonzalo, Andrés R. Alcántara
Catalysts (2019) Vol. 9, Iss. 10, pp. 802-802
Open Access | Times Cited: 83
Pharmacogenetics in Psychiatry: An Update on Clinical Usability
Ron H. N. van Schaik, Daniel J. Müller, Alessandro Serretti, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 71
Ron H. N. van Schaik, Daniel J. Müller, Alessandro Serretti, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 71
A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
Daniela Rodrigues-Amorím, J.M. Olivares, Carlos Spuch, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 56
Daniela Rodrigues-Amorím, J.M. Olivares, Carlos Spuch, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 56
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024
Antoine Yrondi, Hervé Javelot, Bénédicte Nobile, et al.
L Encéphale (2024)
Closed Access | Times Cited: 6
Antoine Yrondi, Hervé Javelot, Bénédicte Nobile, et al.
L Encéphale (2024)
Closed Access | Times Cited: 6
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants
Chin B. Eap, Gerhard Gründer, Pierre Baumann, et al.
The World Journal of Biological Psychiatry (2021) Vol. 22, Iss. 8, pp. 561-628
Open Access | Times Cited: 30
Chin B. Eap, Gerhard Gründer, Pierre Baumann, et al.
The World Journal of Biological Psychiatry (2021) Vol. 22, Iss. 8, pp. 561-628
Open Access | Times Cited: 30
How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNP
X.M. Hart, Friederike Amann, Pierre Baumann, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
X.M. Hart, Friederike Amann, Pierre Baumann, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence
Lorenzo Cellini, Domenico De Donatis, Gerald Zernig, et al.
International Clinical Psychopharmacology (2021) Vol. 37, Iss. 2, pp. 29-37
Open Access | Times Cited: 17
Lorenzo Cellini, Domenico De Donatis, Gerald Zernig, et al.
International Clinical Psychopharmacology (2021) Vol. 37, Iss. 2, pp. 29-37
Open Access | Times Cited: 17
Genetics of antidepressant response and treatment-resistant depression
Annie Chung, Tzu‐Ting Chen, Kuang Lin
Progress in brain research (2023), pp. 25-60
Closed Access | Times Cited: 6
Annie Chung, Tzu‐Ting Chen, Kuang Lin
Progress in brain research (2023), pp. 25-60
Closed Access | Times Cited: 6
Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders
Julia Sagahón‐Azúa, Susanna Edith Medellín‐Garibay, Cinthya Eloisa Chávez‐Castillo, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 14
Julia Sagahón‐Azúa, Susanna Edith Medellín‐Garibay, Cinthya Eloisa Chávez‐Castillo, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 14
Is the bell-shaped dose-response curve of the selective serotonin reuptake inhibitor due to 5-HT1A auto-receptors?
Takeshi Terao, Nobuyoshi Ishii, Hirofumi Hirakawa, et al.
Medical Hypotheses (2020) Vol. 140, pp. 109681-109681
Closed Access | Times Cited: 14
Takeshi Terao, Nobuyoshi Ishii, Hirofumi Hirakawa, et al.
Medical Hypotheses (2020) Vol. 140, pp. 109681-109681
Closed Access | Times Cited: 14
Therapeutic reference range for duloxetine in the treatment of depression revised: A systematic review and meta-analysis
Friederike Amann, M. Kochtyrew, Gerald Zernig, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104077-104077
Open Access | Times Cited: 1
Friederike Amann, M. Kochtyrew, Gerald Zernig, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104077-104077
Open Access | Times Cited: 1
Efficacy and dose-response relationships of antidepressants in the acute treatment of major depressive disorders: a systematic review and network meta-analysis
Shuzhe Zhou, Pei Li, Xiaozhen Lyu, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
Shuzhe Zhou, Pei Li, Xiaozhen Lyu, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics
Joseph F. Goldberg
American Psychiatric Association Publishing eBooks (2024)
Closed Access | Times Cited: 1
Joseph F. Goldberg
American Psychiatric Association Publishing eBooks (2024)
Closed Access | Times Cited: 1
Hyperthermia and Serotonin: The Quest for a “Better Cyproheptadine”
Georg Petroianu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3365-3365
Open Access | Times Cited: 6
Georg Petroianu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3365-3365
Open Access | Times Cited: 6
Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient With Chronic Renal Failure
Domenico De Donatis, Stefano Porcelli, Alessandro Serretti, et al.
Journal of Clinical Psychopharmacology (2020) Vol. 40, Iss. 2, pp. 200-202
Closed Access | Times Cited: 8
Domenico De Donatis, Stefano Porcelli, Alessandro Serretti, et al.
Journal of Clinical Psychopharmacology (2020) Vol. 40, Iss. 2, pp. 200-202
Closed Access | Times Cited: 8
Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients
Domenico De Donatis, Stefano Porcelli, Gerald Zernig, et al.
The World Journal of Biological Psychiatry (2021) Vol. 23, Iss. 3, pp. 183-190
Closed Access | Times Cited: 7
Domenico De Donatis, Stefano Porcelli, Gerald Zernig, et al.
The World Journal of Biological Psychiatry (2021) Vol. 23, Iss. 3, pp. 183-190
Closed Access | Times Cited: 7
Neglected but not negligible aspects of antidepressants and their availability in bipolar depression
Takeshi Terao
Brain and Behavior (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 5
Takeshi Terao
Brain and Behavior (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 5
Precision medicine in mood disorders
Alessandro Serretti
Psychiatry and Clinical Neurosciences Reports (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 3
Alessandro Serretti
Psychiatry and Clinical Neurosciences Reports (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 3
Evidence Basis for Pharmacogenetic Testing in Psychiatry
Priya Hays
Research Review (2022)
Open Access | Times Cited: 3
Priya Hays
Research Review (2022)
Open Access | Times Cited: 3
Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels
Lorenzo Cellini, Domenico De Donatis, Laura Mercolini, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 6, pp. 694-696
Closed Access | Times Cited: 4
Lorenzo Cellini, Domenico De Donatis, Laura Mercolini, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 6, pp. 694-696
Closed Access | Times Cited: 4
Mirtazapine blood levels and antidepressant response
Domenico De Donatis, Marco Verrastro, Giuseppe Fanelli, et al.
International Journal of Psychiatry in Clinical Practice (2024), pp. 1-5
Closed Access
Domenico De Donatis, Marco Verrastro, Giuseppe Fanelli, et al.
International Journal of Psychiatry in Clinical Practice (2024), pp. 1-5
Closed Access
DREAM: an adaptive, randomised, placebo-controlled trial of duloxetine for reducing leg pain in people with chronic sciatica—trial protocol
Hanan McLachlan, Christopher G. Maher, Chung‐Wei Christine Lin, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e096796-e096796
Open Access
Hanan McLachlan, Christopher G. Maher, Chung‐Wei Christine Lin, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e096796-e096796
Open Access
Measuring serum concentrations of psychotropics- Valuable tool for decision making or waste of money?
Heinz Grunze
European Neuropsychopharmacology (2023) Vol. 76, pp. 20-22
Closed Access | Times Cited: 1
Heinz Grunze
European Neuropsychopharmacology (2023) Vol. 76, pp. 20-22
Closed Access | Times Cited: 1
Pharmacokinetic and Pharmacodynamic Principles
Gerald Zernig, Christoph Hiemke
Springer eBooks (2020), pp. 1-19
Closed Access | Times Cited: 1
Gerald Zernig, Christoph Hiemke
Springer eBooks (2020), pp. 1-19
Closed Access | Times Cited: 1
